Market Research Future (MRFR) studied the global dermal fillers market 2020 through the review period from 2016 to 2025. By 2025, the dermal fillers market is expected to thrive at 13.2% CAGR. The global dermal fillers market value is expected to rise exponentially due to growing preference for non-invasive aesthetic surgeries among people. The expansion of the global dermal fillers market can be attributed to increasing trend of anti-ageing treatments and face-lifting dermatology procedures. The growing awareness about several skin care solutions available in the market and extensive demand for diagnostic and treatment solutions for skin disorders can also influence the expansion of the dermal filler market in the near future.
The increase in awareness about harmful impact of fillers post-surgery can pose threat to the market rise in the years ahead. In addition, high expense of aesthetic surgeries can hamper the derma fillers market growth, along with the presence of several unregistered practitioners. However, increase in success rate of surgeries can counter the market slow-down in the approaching years.
The segment analysis of the global derma fillers market is studied by type, brand, and application. Segment insights of the derma filler market offers comprehensive analysis to investors that aid them explore untapped market potential.
The type-based segments of the global dermal fillers market are collagen, hyaluronic acid, calcium hydroxylapatite, and polymers & particles. The hyaluronic acid segment is expected to rise at the highest CAGR in the study period as the demand for anti-ageing solutions is high. The segment is expected to acquire considerable market value of USD 1,154.96 Mn in 2018. Innovations and new launches of hyaluronic acid products can benefit the market in the review tenure. The calcium hydroxylapatite can generate considerable financial gains for the global market during the analysis tenure.
The application-based segments of the dermal fillers market are lip treatment, dermal fillers, and facial line correction treatment. The lip treatment segment can acquire substantial market value by 2025. The upscaling demand for different types of aesthetic-boosting beauty solutions and rise in consciousness about beauty in women are expected to fuel the application segments expansion in the review period. The lip treatment segment is likely to rise at high pace as lip surgeries are becoming popularity among people. Moreover, lip surgeries are sought-after treatment among celebrities. The facial line correction segment can have considerable financial gain for the market in the near future.
In North America, the surge in number of people undergoing cosmetic surgeries is expected to favor the regional derma fillers market. Alterations in lifestyle is likely to accelerate the market surge in the near future. The introduction of effective cosmetic solutions and development in dermal fillers technologies can favor the regional market. The adoption of effective product differentiation strategies for sustainable development can also strengthen the regional presence of the derma filler market in North America. The US is likely to lead North America market in the near future.
In Europe, the rise in number of facial injectable surgeries among both women and men can boost the market growth in the near future. In Asia Pacific, the availability of highly skilled healthcare professional, such as; surgeons and dermatologist, can increase the demand for dermal fillers and other dermatology appliances and devices. The high sales of dermal fillers solution in APAC can benefit the regional market in the years to come.
MEA derma filler market is likely to exhibit the slowest growth pace due to limited access to cosmetic facilities that are available in the market. However, investors exploring untapped market opportunities in the region and funding new products launches can promote the derma fillers market in Middle East Asia. In the Africa region, the market growth curve can show lag due to beauty norms in underdeveloped nations. On the contrary, regions, such as; Saudi Arabia, and Kuwait are predicted to contribute significantly to fostering the regional market growth.
Galderma Laboratories, LP (Switzerland), Teoxane Laboratories (Switzerland), Dr. Korman Laboratories (Israel), SciVision Biotech Inc. (Taiwan), Allergan (Ireland), Merz Pharma (Germany), Sinclair Pharma (UK), Medytox (South Korea), and Suneva Medical (US). Strategies adopted by different marketers to boost their growth and sustain amidst the COVID 19 pandemic can favor the market upsurge in the years to come. Developments in the supply chain analytics to curb supply demand gap and investors exploring untapped market potential can add momentum to the market.